Loading...
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
Aims: The pathophysiological role of iron in Parkinson's disease (PD) was assessed by a chelation strategy aimed at reducing oxidative damage associated with regional iron deposition without affecting circulating metals. Translational cell and animal models provided concept proofs and a delayed...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Mary Ann Liebert, Inc.
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4060813/ https://ncbi.nlm.nih.gov/pubmed/24251381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ars.2013.5593 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|